DM0000: The mark consists of the word "XIAFLEX" shown in blue with an orange wave design completing the "A" and "F" on the first line, "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM" is shown in grey on the second line, and "TRANSFORMING TREATMENT" is shown on the third line in orange.
GS0161: Printed educational materials for patients and health care professionals on medical issues
CC0000: The color(s) blue, grey and orange is/are claimed as a feature of the mark.
GS0441: Providing online medical information
DS0000: "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM"
Case File Event Statements
5/18/2010 - 14 years ago
3 - NOTICE OF DESIGN SEARCH CODE MAILEDType:MDSC
5/15/2010 - 14 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
5/17/2010 - 14 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
6/10/2011 - 13 years ago
12 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
8/25/2010 - 14 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
8/27/2010 - 14 years ago
5 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
9/9/2010 - 14 years ago
6 - ASSIGNED TO LIEType:ALIE
9/9/2010 - 14 years ago
7 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
10/12/2010 - 14 years ago
8 - PUBLISHED FOR OPPOSITIONType:PUBO
10/12/2010 - 14 years ago
9 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
12/7/2010 - 14 years ago
10 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
6/6/2011 - 13 years ago
11 - TEAS STATEMENT OF USE RECEIVEDType:EISU
6/6/2011 - 13 years ago
13 - USE AMENDMENT FILEDType:IUAF
6/10/2011 - 13 years ago
14 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
6/25/2015 - 9 years ago
23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP